Drug Shortage Report for JAMP IPRATROPIUM HFA

Last updated on 2025-04-10 History
Report ID 250065
Drug Identification Number 02542587
Brand name JAMP IPRATROPIUM HFA
Common or Proper name Ipratropium Bromide Pressurized Inhalation Solution
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) IPRATROPIUM BROMIDE
Strength(s) 20MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 200
ATC code R03BB
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-02-10
Estimated end date 2025-04-21
Actual end date
Shortage status Actual shortage
Updated date 2025-04-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2025-04-10 French Compare
v6 2025-04-10 English Compare
v5 2025-03-03 French Compare
v4 2025-03-03 English Compare
v3 2025-02-11 English Compare
v2 2025-02-10 French Compare
v1 2025-02-10 English Compare

Showing 1 to 7 of 7